0001019056-20-000452.txt : 20200804
0001019056-20-000452.hdr.sgml : 20200804
20200731165035
ACCESSION NUMBER: 0001019056-20-000452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200727
FILED AS OF DATE: 20200729
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harsanyi Zsolt
CENTRAL INDEX KEY: 0001380184
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 201066619
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD., SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
harsanyi.xml
X0306
4
2020-07-27
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001380184
Harsanyi Zsolt
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
0
0
0
Stock Option (right to buy)
41.16
2020-07-27
4
D
0
1339
D
2026-08-03
Common Stock
1339
0
D
Stock Option (right to buy)
30.10
2020-07-27
4
D
0
892
D
2027-06-01
Common Stock
892
0
D
Stock Option (right to buy)
76.86
2020-07-27
4
D
0
1785
D
2028-06-01
Common Stock
1785
0
D
Stock Option (right to buy)
8.56
2020-07-27
4
A
0
1322
A
2030-07-26
Common Stock
1322
1322
D
Stock Option (right to buy)
8.56
2020-07-27
4
A
0
170
A
2030-07-26
Common Stock
170
170
D
Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.
These options vested in three approximately equal annual installments beginning on August 3, 2017.
In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.
These options vested in three approximately equal annual installments beginning on June 1, 2018.
These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested.
These options vest in full on the one year anniversary of the date of grant.
These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant.
/s/ Carl A. Valenstein, attorney-in-fact
2020-07-29